ADM Exam Prep Tool and In-training Exam for ADM Fellows: ADePT & AMSAMs

Addiction e-Practice Test (ADePT)

ADePT is a cost effective tool for your Board test preparation developed by an academic panel of addiction medicine experts of The Addiction Medicine Foundation’s ADePT Committee, Chaired by Dr. Lou Baxter.

This evidence based, referenced, online Addiction Medicine Practice Test is a comprehensive evaluation and assessment tool for addiction medicine knowledge. It is designed to prepare physicians for certification in addiction medicine, as well as an in-training exam for addiction medicine fellowships.

This tool is a cognitive test with feedback on areas of strengths and weaknesses. It is a helpful exercise for physicians planning to take the 2017 addiction medicine certification examination, as well as for physicians wishing to assess their knowledge in the field. As an in-training examination, it also assesses the knowledge base of addiction medicine Fellows upon entry and periodically throughout their subspecialty training.

Why Choose This Prep Tool?

Maximize your opportunity for success with a leader in addiction medicine training.

  • CME Credits.  Earn 5 AMA PRA Category 1 Credits™.
  • Mimics Real Exam Administration.  Designed to simulate the actual addiction medicine certification examination
  • Psychometrics.  Analysis of this assessment tool is being performed by the National Board of Medical Examiners.
  • Advantage.  Helps assess learning gaps in core content.
  • Savings. Save time and money by knowing which areas you need to give priority in studying.
  • Convenience. Test on your own schedule. A laptop or tablet is all you need.
  • Comprehensive Question Bank. Two hundred and fifty (250).

Addiction Medicine Self Assessment Modules (AMSAMs)

AMSAMs provide physicians the opportunity to be ‘in the know’ with literature in the field of addiction medicine.

A panel of experts from the Foundation’s Lifelong Learning and Self-Assessment Committee has selected 70 significant journal articles to cover the range of critical topics related to the science and clinical practice of addiction medicine. Each module contains a link to the journal article, and 4 questions. Immediate feedback is given.

Earn while you learn.  Maximum of 70 AMA PRA Category 1 Credits™ available.

Access 24/7.  Unlimited online access.

These AMSAMs are designed to: 

• Facilitate knowledge assessment and improvement
• Promote practice excellence
• Advance commitment to professionalism

By completing evidence-based addiction articles with immediate self-assessment, physicians may increase their confidence and better assure their patients that they have aspired to a high standard of education and professionalism in the field. Continuous development of the physician knowledge set assures the public that a high standard of care is being sought.

Why Choose The Addiction Medicine Foundation?

TAMF has experience and a solid 10 year reputation for bringing physicians into the field by developing content and competencies for addiction medicine experts.  TAMF developed the standards for post-graduate addiction medicine training, and has been at the forefront in credentialing and expanding the addiction medicine workforce.

Our work was the basis for the formal recognition of the field of addiction medicine in 2016 by the American Board of Medical Specialties and the Accreditation Council for Graduate Medical Education.  We’ve led the strategic national campaign to bring the field of addiction medicine into the “House of Medicine”.

We are leaders in the national collaboration, development and implementation of addiction medicine training.

Registration Rates

(Please click the appropriate pricing link below to register and you will be directed to Medconcert to get started.)

ABAM Diplomate Non Diplomate








$249*  $349

*ABAM Diplomates:  A Discount Code must be used at the time of registration for proper pricing.  If you do not have a Discount Code, please contact us at 301-656-3880 or

INSTRUCTIONS:  Accessing ADePT and AMSAMs after registering.


There has been no commercial support or influence on this activity from industry or pharma.